Calidi Biotherapeutics, Inc. Cash and Restricted Cash
Calidi Biotherapeutics, Inc. (CLDI) had Cash and Restricted Cash of $4.29 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-13
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $4.29M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.85M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.82M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $10.59M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $4.29M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $6.85M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $5.82M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $10.59M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $5.38M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $10.78M 10-Q · filed 2026-05-14 | |
| 2024-12-31 | $9.81M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $2.12M 10-Q · filed 2025-11-13 | |
| 2024-06-30 | $1.05M 10-Q · filed 2025-08-08 | |
| 2024-03-31 | $1.36M 10-Q · filed 2025-05-14 | |
| 2023-12-31 | $2.17M 10-K · filed 2026-03-27 | |
| 2023-09-30 | $10.37M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $2.29M 10-Q · filed 2024-08-13 | $669.87K 10-Q · filed 2023-08-21 |
| 2023-03-31 | $1.14M 10-Q · filed 2024-05-14 | $82.83K 10-Q · filed 2023-05-15 |
| 2022-12-31 | $590.00K 10-K · filed 2025-03-31 | $93.89K 10-K · filed 2023-03-31 |
| 2022-09-30 | $300.00K 10-Q · filed 2023-11-14 | $39.94K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $328.84K 10-Q · filed 2023-08-21 | |
| 2022-03-31 | $597.52K 10-Q · filed 2023-05-15 | |
| 2021-12-31 | $2.24M 10-K · filed 2024-03-15 | $1.06M 10-Q · filed 2022-08-10 |
| 2021-09-30 | $1.20M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $95.00K 10-Q · filed 2022-08-10 | |
| 2021-03-23 | $0.00 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |